ArticleJournal of cellular and molecular medicine2020

Pharmacological rationale for antihypertensive drug choice on COVID-19-affected patients: ACEI/ARB might not increase their susceptibility.

Hong-Jin Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.